Neuroglee Therapeutics
Discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Sep 2021.)
Singapore Singapore (HQ)
Authorizing premium user...